Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Other financing activities: 2015-2025

Historic Other financing activities for Cartesian Therapeutics (RNAC) over the last 2 years, with Sep 2025 value amounting to $43,000.

  • Cartesian Therapeutics' Other financing activities was N/A to $43,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $588,000, marking a year-over-year change of. This contributed to the annual value of $66,000 for FY2024, which is N/A change from last year.
  • Per Cartesian Therapeutics' latest filing, its Other financing activities stood at $43,000 for Q3 2025, which was up 72.00% from $25,000 recorded in Q2 2025.
  • Over the past 5 years, Cartesian Therapeutics' Other financing activities peaked at $454,000 during Q1 2025, and registered a low of $25,000 during Q2 2025.
  • Its 2-year average for Other financing activities is $147,000, with a median of $54,500 in 2024.